Avalo Therapeutics (AVTX) Q3 2024 Earnings

Aug 12Confirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
-141
-94.04
-47.07
-0.11

Details

Expected EPS
-6.7
Actual EPS
-14.07
Surprise EPS
-7.37
Surprise Percent
-110%

Description

⁨Avalo Therapeutics⁩ (⁦AVTX⁩) has reported earnings of ⁦-14.07⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts